Pharmaceutical Contract Manufacturing Market Forecasts to 2028 - Global Analysis By Service (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development & Manufacturing, Drug Discovery, Preclinical Studies, Medical Coding & Writing, Monitoring, Clinical Data Management, Bio-Statistics, Site Management and Protocol Development), Molecule Type (Small Molecules and Large Molecules), End User and By Geography
|
Years Covered |
2020-2028 |
|
Estimated Year Value (2022) |
US $143.02 BN |
|
Projected Year Value (2028) |
US $210.34 BN |
|
CAGR (2022 - 2028) |
6.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Pharmaceutical Contract Manufacturing Market is accounted for $143.02 billion in 2022 and is expected to reach $210.34 billion by 2028 growing at a CAGR of 6.6% during the forecast period. Pharmaceutical contract manufacturing is the method through which pharmaceutical medications are made under contract. It is the practice of contracting out the job of creating medicine including pills, tablets and capsules for consumption by a third party. A variety of services such as drug development, manufacturing, and commercial production, documentation of compliance with FDA regulatory standards, and pre-formulation are offered by pharma contract manufacturing businesses to pharmaceutical corporations. It relieves pharmaceutical companies from the cost and burden of hiring and training workers during periods of labor shortage.
According to the CPhI Pharma Index 2020, India is the primary beneficiary of API manufacturing and CRO chemistry services outsourcing, rebalancing away from China.
Market Dynamics:
Driver:
High cost of in-house drug development
For small- and medium-sized pharmaceutical enterprises, the process of drug research and development is highly costly and time-consuming. The cost of producing the formulation and developing drugs internally goes up as a result. Factors such as high failure rates for medications, high costs of discovery and lack of funding forces the pharmaceutical firms to outsource their drug development procedures to pharmaceutical contract manufacturing which propels the market's expansion.
Restraint:
Compliance with regulatory guidelines
Poor quality of produced pharmaceuticals and the related authority’s noncompliance with standards and regulations has major ramifications for the company and its brand name. In the pharmaceutical sector, the contractor's brand is used to market the manufactured medication ingredient or formulation. Large volumes of data must be given to the regulatory authorities in order to accomplish properly. Data processing and submissions of various formulas become challenging, which raises the possibility of regulatory filing mistakes. This aspect will probably impede market expansion.
Opportunity:
Raising demand in major economies
Since the labor costs and manpower advantages, emerging nations are centers for outsourcing bioprocesses. Competitive companies are encouraged to engage in developing markets by the availability of modern manufacturing technology and the cheap production and labor costs offered by emerging nations. Further the growing interest of pharmaceutical companies in outsourcing drug discovery due to the constant rise in vaccine demand, drying up of the pipeline for antibiotics, and rising R&D costs is fueling the market expansion.
Threat:
Implementation of serialization
Serialization is the act of providing each service or product item a unique identification by utilizing a specified coding type, enabling it to be tracked and traced along the supply chain. The implementation of a reliable pharma serialization solution necessitates a substantial financial investment in software, hardware, employee training, and manufacturing lines that are properly prepared. Consequently, the market might encounter a problem as a result.
Covid-19 Impact
Several healthcare markets were either favourably or badly influenced by the COVID-19 epidemic. But the pharmaceutical contract development and manufacturing business has benefited hugely. The outbreak sparked the development of various pharmaceutical products, including antiviral vaccines, antibody therapies, and corona virus-related vaccines. To ensure the long-term viability of their businesses, pharmaceutical companies were encouraged to work with contract development and manufacturing companies.
The active pharmaceutical ingredient (API) manufacturing segment is expected to be the largest during the forecast period
The active pharmaceutical ingredient (API) manufacturing segment is estimated to have a lucrative growth. API is the acetaminophen contained in a painkiller pill. APIs are produced by processing chemical compounds. It is an active component in a pharmaceutical drug that produces the required effect on the body to treat a condition. Its therapeutic impact and improved preventative care is accelerating the segment’s growth.
The big pharma segment is expected to have the highest CAGR during the forecast period
The big pharma segment is anticipated to witness the fastest CAGR growth during the forecast period. Growing investment in the development of cell and gene therapies, an increase in the number of biologics undergoing pipeline investigations and the rising need for targeted pharmacological treatments are the key factors projected to propel the segment’s expansion.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. A significant number of pharmaceutical businesses operate in this area. Generics are in extremely high demand, and as a result, research funding for pharmaceutical contract development and manufacture has skyrocketed. The cash-rich character of American businesses is to blame for the industry's monopoly status in contract manufacturing.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the spout of significant investments. Due to their rising manufacturing capabilities, nations like Singapore, China and India have been identified as important participants in the pharmaceutical sector. This expansion is made possible by an increase in the number of businesses outsourcing work to these nation’s emerging economies.
Key players in the market
Some of the key players profiled in the Pharmaceutical Contract Manufacturing Market include Thermo Fisher Scientific Inc, Boehringer Ingelheim Group, Lonza Group AG, Accenture plc, Catalent Inc, Pfizer CentreSource, Cognizant Technology Solutions, ATOS SE, Catalent, Inc., Covance, Inc, Genpact Limited, Quintiles Transnational Corporation, Abbvie, Inc., Baxter International Inc., Reddy’s Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd. and Piramal Enterprises Ltd.
Key Developments:
In May 2023, Accenture has agreed to acquire Objectivity, a digital engineering firm specializing in cloud and platform development services that help clients accelerate their transformation journey for rapid innovation.
In March 2023, Aurobindo Pharma announced that its subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market cancer drug Lenalidomide Capsules, in different strengths.
In September 2022, Thermo Fisher Scientific Inc. unveiled the Thermo Scientific™ DynaSpin™ Single-Use Centrifuge system at the Bioprocess International annual conference in Boston, MA. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting.
Services Covered:
• Active Pharmaceutical Ingredient (API) Manufacturing
• Finished Dosage Formulation (FDF) Development & Manufacturing
• Drug Discovery
• Preclinical Studies
• Medical Coding & Writing
• Monitoring
• Clinical Data Management
• Bio-Statistics
• Site Management
• Protocol Development
Molecule Types Covered:
• Small Molecules
• Large Molecules
End Users Covered:
• Big Pharma
• Small & Medium Sized Pharma
• Generic Pharma
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pharmaceutical Contract Manufacturing Market, By Service
5.1 Introduction
5.2 Active Pharmaceutical Ingredient (API) Manufacturing
5.3 Finished Dosage Formulation (FDF) Development & Manufacturing
5.4 Drug Discovery
5.5 Preclinical Studies
5.6 Medical Coding & Writing
5.7 Monitoring
5.8 Clinical Data Management
5.9 Bio-Statistics
5.10 Site Management
5.11 Protocol Development
6 Global Pharmaceutical Contract Manufacturing Market, By Molecule Type
6.1 Introduction
6.2 Small Molecules
6.3 Large Molecules
7 Global Pharmaceutical Contract Manufacturing Market, By End User
7.1 Introduction
7.2 Big Pharma
7.3 Small & Medium Sized Pharma
7.4 Generic Pharma
8 Global Pharmaceutical Contract Manufacturing Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Thermo Fisher Scientific Inc
10.2 Boehringer Ingelheim Group
10.3 Lonza Group AG
10.4 Accenture plc
10.5 Catalent Inc
10.6 Pfizer CentreSource
10.7 Cognizant Technology Solutions
10.8 ATOS SE
10.9 Catalent, Inc.
10.10 Covance, Inc
10.11 Genpact Limited
10.12 Quintiles Transnational Corporation
10.13 Abbvie, Inc.
10.14 Baxter International Inc.
10.15 Reddy’s Laboratories Ltd.
10.16 Aurobindo Pharma
10.17 Pfizer, Inc.
10.18 The Almac Group
10.19 Teva Pharmaceutical Industries Ltd.
10.20 Piramal Enterprises Ltd
List of Tables
1 Global Pharmaceutical Contract Manufacturing Market Outlook, By Region (2020-2028) ($MN)
2 Global Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
3 Global Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
4 Global Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
5 Global Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
6 Global Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
7 Global Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
8 Global Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
9 Global Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
10 Global Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
11 Global Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
12 Global Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
13 Global Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
14 Global Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
15 Global Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
16 Global Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
17 Global Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
18 Global Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
19 Global Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
20 North America Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
21 North America Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
22 North America Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
23 North America Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
24 North America Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
25 North America Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
26 North America Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
27 North America Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
28 North America Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
29 North America Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
30 North America Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
31 North America Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
32 North America Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
33 North America Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
34 North America Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
35 North America Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
36 North America Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
37 North America Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
38 North America Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
39 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
40 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
41 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
42 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
43 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
44 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
45 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
46 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
47 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
48 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
49 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
50 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
51 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
52 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
53 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
54 Europe Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
55 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
56 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
57 Europe Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
58 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
59 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
60 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
61 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
62 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
63 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
64 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
65 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
66 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
67 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
68 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
69 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
70 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
71 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
72 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
73 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
74 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
75 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
76 Asia Pacific Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
77 South America Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
78 South America Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
79 South America Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
80 South America Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
81 South America Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
82 South America Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
83 South America Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
84 South America Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
85 South America Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
86 South America Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
87 South America Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
88 South America Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
89 South America Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
90 South America Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
91 South America Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
92 South America Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
93 South America Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
94 South America Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
95 South America Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
96 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Country (2020-2028) ($MN)
97 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Service (2020-2028) ($MN)
98 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Active Pharmaceutical Ingredient (API) Manufacturing (2020-2028) ($MN)
99 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Finished Dosage Formulation (FDF) Development & Manufacturing (2020-2028) ($MN)
100 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Drug Discovery (2020-2028) ($MN)
101 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Preclinical Studies (2020-2028) ($MN)
102 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Medical Coding & Writing (2020-2028) ($MN)
103 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Monitoring (2020-2028) ($MN)
104 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Clinical Data Management (2020-2028) ($MN)
105 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Bio-Statistics (2020-2028) ($MN)
106 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Site Management (2020-2028) ($MN)
107 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Protocol Development (2020-2028) ($MN)
108 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Molecule Type (2020-2028) ($MN)
109 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Small Molecules (2020-2028) ($MN)
110 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Large Molecules (2020-2028) ($MN)
111 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By End User (2020-2028) ($MN)
112 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Big Pharma (2020-2028) ($MN)
113 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Small & Medium Sized Pharma (2020-2028) ($MN)
114 Middle East & Africa Pharmaceutical Contract Manufacturing Market Outlook, By Generic Pharma (2020-2028) ($MN)
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.